Alcon (ALC)
(Delayed Data from NYSE)
$78.77 USD
-0.07 (-0.09%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $78.79 +0.02 (0.03%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth A Momentum B VGM
Company Summary
Headquartered in Geneva, Switzerland Alcon Inc. (ALC) researches, develops, manufactures, distributes, and sells a full suite of eye care products. Founded in 1945, Alcon was first acquired by a Swiss subsidiary of Nestlé S.A. and began operating as a wholly owned subsidiary of Nestlé until 2002. From Mar 20, 2002 until its 2011-merger into Novartis, Alcon was publicly listed and traded on the NYSE. In 2011, Novartis completed the acquisition of 100% stake in Alcon.
Effective Jan 1, 2018, Novartis returned to Alcon the management and reporting of over-the-counter ocular health products and certain surgical ...
Company Summary
Headquartered in Geneva, Switzerland Alcon Inc. (ALC) researches, develops, manufactures, distributes, and sells a full suite of eye care products. Founded in 1945, Alcon was first acquired by a Swiss subsidiary of Nestlé S.A. and began operating as a wholly owned subsidiary of Nestlé until 2002. From Mar 20, 2002 until its 2011-merger into Novartis, Alcon was publicly listed and traded on the NYSE. In 2011, Novartis completed the acquisition of 100% stake in Alcon.
Effective Jan 1, 2018, Novartis returned to Alcon the management and reporting of over-the-counter ocular health products and certain surgical diagnostic medications previously transferred from Alcon in 2016. Finally, Novartis shareholders approved the spin-off of Alcon on Feb 28, 2019 and the transaction was consummated on Apr 9, 2019. Following the spin-off, Alcon became a standalone, independent company.
At present Alcon operates within two segments, Surgical and Vision Care.The Surgical segment (2023 revenues of $5.31 billion, up 8% from 2022 at constant exchange rate or CER) is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures.
The Vision Care segment ($4.10 billion, up 12%) comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers.
General Information
Alcon
Rue Louis-d`Affry 6
Fribourg, V8 1701
Phone: 817-293-0450
Fax: 817-916-2652
Web: http://www.alcon.com
Email: investor.relations@alcon.com
Industry | Medical - Instruments |
Sector | Medical |
Fiscal Year End | December |
Last Reported Quarter | 3/31/2024 |
Exp Earnings Date | 5/14/2024 |
EPS Information
Current Quarter EPS Consensus Estimate | 0.72 |
Current Year EPS Consensus Estimate | 3.05 |
Estimated Long-Term EPS Growth Rate | 12.80 |
Exp Earnings Date | 5/14/2024 |
Price and Volume Information
Zacks Rank | |
Yesterday's Close | 78.84 |
52 Week High | 88.23 |
52 Week Low | 69.44 |
Beta | 0.91 |
20 Day Moving Average | 892,654.19 |
Target Price Consensus | 91.14 |
4 Week | -5.43 |
12 Week | 5.05 |
YTD | 0.83 |
4 Week | -2.56 |
12 Week | 2.14 |
YTD | -5.70 |
Shares Outstanding (millions) | 493.10 |
Market Capitalization (millions) | 38,841.48 |
Short Ratio | NA |
Last Split Date | NA |
Dividend Yield | 0.00% |
Annual Dividend | $0.00 |
Payout Ratio | 0.00 |
Change in Payout Ratio | 0.00 |
Last Dividend Payout / Amount | NA / $0.00 |
Fundamental Ratios
P/E (F1) | 25.84 |
Trailing 12 Months | 28.64 |
PEG Ratio | 2.02 |
vs. Previous Year | 66.67% |
vs. Previous Quarter | 6.06% |
vs. Previous Year | 8.34% |
vs. Previous Quarter | 0.99% |
Price/Book | 1.88 |
Price/Cash Flow | 15.02 |
Price / Sales | 4.11 |
3/31/24 | NA |
12/31/23 | 6.75 |
9/30/23 | 6.15 |
3/31/24 | NA |
12/31/23 | 4.63 |
9/30/23 | 4.18 |
3/31/24 | NA |
12/31/23 | 2.28 |
9/30/23 | 2.21 |
3/31/24 | NA |
12/31/23 | 1.34 |
9/30/23 | 1.29 |
3/31/24 | NA |
12/31/23 | 14.38 |
9/30/23 | 13.20 |
3/31/24 | NA |
12/31/23 | 10.30 |
9/30/23 | 4.85 |
3/31/24 | NA |
12/31/23 | 8.80 |
9/30/23 | 6.83 |
3/31/24 | NA |
12/31/23 | 41.83 |
9/30/23 | 40.87 |
3/31/24 | NA |
12/31/23 | 1.84 |
9/30/23 | 1.86 |
3/31/24 | NA |
12/31/23 | 0.22 |
9/30/23 | 0.23 |
3/31/24 | NA |
12/31/23 | 18.22 |
9/30/23 | 18.48 |